Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | aldehyde dehydrogenase 1 family, member A1 | Starlite/ChEMBL | No references |
Homo sapiens | polymerase (DNA directed), beta | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Mycobacterium tuberculosis | Succinate-semialdehyde dehydrogenase [NADP+] dependent (SSDH) GabD1 | aldehyde dehydrogenase 1 family, member A1 | 501 aa | 456 aa | 33.3 % |
Trypanosoma cruzi | mitochondrial DNA polymerase beta-PAK, putative | polymerase (DNA directed), beta | 335 aa | 303 aa | 32.3 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | mitochondrial DNA polymerase beta, putative | 0.0365 | 1 | 1 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0211 | 0.4959 | 0.5 |
Loa Loa (eye worm) | CMGC/DYRK/DYRK2 protein kinase | 0.0211 | 0.4959 | 0.7062 |
Loa Loa (eye worm) | hypothetical protein | 0.0117 | 0.189 | 0.2578 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0073 | 0.0474 | 0.0825 |
Onchocerca volvulus | Putative endochitinase | 0.0082 | 0.0768 | 0.2052 |
Trypanosoma cruzi | CMGC/DYRK protein kinase, putative | 0.0097 | 0.1241 | 0.1135 |
Trypanosoma cruzi | dual specificity tyrosine-phosphorylation-regulated kinase 2, putative | 0.0211 | 0.4959 | 0.4898 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0097 | 0.1241 | 0.1195 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0192 | 0.4357 | 1 |
Toxoplasma gondii | cell-cycle-associated protein kinase DYRK2, putative | 0.0211 | 0.4959 | 1 |
Onchocerca volvulus | 0.0117 | 0.189 | 1 | |
Schistosoma mansoni | hypothetical protein | 0.027 | 0.6895 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0211 | 0.4959 | 0.6985 |
Trypanosoma brucei | dual specificity tyrosine-phosphorylation-regulated kinase 2, putative | 0.0211 | 0.4959 | 0.4245 |
Plasmodium vivax | hypothetical protein, conserved | 0.0117 | 0.189 | 0.5 |
Loa Loa (eye worm) | haspin protein kinase | 0.027 | 0.6895 | 0.989 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0211 | 0.4959 | 0.5 |
Leishmania major | chitinase | 0.0073 | 0.0479 | 0.0005 |
Echinococcus granulosus | serine:threonine protein kinase haspin | 0.027 | 0.6895 | 1 |
Brugia malayi | Protein kinase domain containing protein | 0.0097 | 0.1241 | 0.1189 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta, putative | 0.0365 | 1 | 1 |
Entamoeba histolytica | protein kinase domain containing protein | 0.0097 | 0.1241 | 0.1702 |
Loa Loa (eye worm) | haspin protein kinase | 0.0272 | 0.697 | 1 |
Trypanosoma cruzi | CMGC/DYRK protein kinase, putative | 0.0097 | 0.1241 | 0.1135 |
Brugia malayi | endochitinase | 0.0082 | 0.0768 | 0.0451 |
Brugia malayi | Hepatocellular carcinoma-associated antigen 59 family protein | 0.0117 | 0.189 | 0.2199 |
Echinococcus multilocularis | dual specificity | 0.0211 | 0.4959 | 0.6985 |
Schistosoma mansoni | hypothetical protein | 0.0117 | 0.189 | 0.2205 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0211 | 0.4959 | 0.5 |
Echinococcus granulosus | Hepatocellular carcinoma associated antigen 59 | 0.0117 | 0.189 | 0.2205 |
Giardia lamblia | Kinase, CMGC DYRK | 0.0211 | 0.4959 | 0.5 |
Echinococcus granulosus | serine:threonine protein kinase haspin | 0.027 | 0.6895 | 1 |
Loa Loa (eye worm) | microfilarial chitinase | 0.0072 | 0.0414 | 0.0423 |
Echinococcus granulosus | dual specificity | 0.0211 | 0.4959 | 0.6985 |
Brugia malayi | GSG2 | 0.027 | 0.6895 | 1 |
Leishmania major | protein kinase, putative,dual-specificity protein kinase, putative | 0.0211 | 0.4959 | 0.4708 |
Toxoplasma gondii | hypothetical protein | 0.0117 | 0.189 | 0.3811 |
Loa Loa (eye worm) | chitinase I | 0.0073 | 0.0479 | 0.0517 |
Mycobacterium tuberculosis | Probable aldehyde dehydrogenase | 0.0073 | 0.0474 | 0.0825 |
Entamoeba histolytica | protein kinase, putative | 0.0211 | 0.4959 | 1 |
Trypanosoma brucei | mitochondrial DNA polymerase beta-PAK | 0.0173 | 0.372 | 0.283 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta-PAK, putative | 0.0173 | 0.372 | 0.3643 |
Onchocerca volvulus | Putative endochitinase | 0.0082 | 0.0768 | 0.2052 |
Echinococcus granulosus | dual specificity | 0.0097 | 0.1241 | 0.1195 |
Toxoplasma gondii | aldehyde dehydrogenase | 0.0073 | 0.0474 | 0.0956 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0211 | 0.4959 | 0.5 |
Echinococcus multilocularis | Hepatocellular carcinoma associated antigen 59 | 0.0117 | 0.189 | 0.2205 |
Echinococcus granulosus | dual specificity | 0.0211 | 0.4959 | 0.6985 |
Entamoeba histolytica | protein kinase domain containing protein | 0.0211 | 0.4959 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0097 | 0.1241 | 0.1702 |
Trypanosoma brucei | mitochondrial DNA polymerase beta | 0.0365 | 1 | 1 |
Mycobacterium ulcerans | hypothetical protein | 0.0192 | 0.4357 | 1 |
Echinococcus granulosus | serine:threonine protein kinase haspin | 0.027 | 0.6895 | 1 |
Plasmodium falciparum | conserved protein, unknown function | 0.0117 | 0.189 | 0.5 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0211 | 0.4959 | 0.5 |
Brugia malayi | Endochitinase | 0.0082 | 0.0768 | 0.0451 |
Onchocerca volvulus | 0.0117 | 0.189 | 1 | |
Trichomonas vaginalis | CMGC family protein kinase | 0.0211 | 0.4959 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0094 | 0.1166 | 0.152 |
Entamoeba histolytica | protein kinase, putative | 0.0097 | 0.1241 | 0.1702 |
Loa Loa (eye worm) | CMGC/DYRK/DYRK1 protein kinase | 0.0097 | 0.1241 | 0.1631 |
Leishmania major | serine/threonine-protein kinase, putative,protein kinase, putative | 0.0097 | 0.1241 | 0.0805 |
Leishmania major | mitochondrial DNA polymerase beta-PAK, putative | 0.0173 | 0.372 | 0.3407 |
Brugia malayi | hypothetical protein | 0.027 | 0.6895 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0094 | 0.1166 | 0.152 |
Loa Loa (eye worm) | haspin protein kinase | 0.027 | 0.6895 | 0.989 |
Entamoeba histolytica | protein kinase, putative | 0.0097 | 0.1241 | 0.1702 |
Brugia malayi | Dual-specificity tyrosine-phosphorylation regulated kinase 2 | 0.0211 | 0.4959 | 0.6983 |
Echinococcus multilocularis | serine:threonine protein kinase haspin | 0.027 | 0.6895 | 1 |
Echinococcus multilocularis | serine:threonine protein kinase haspin | 0.027 | 0.6895 | 1 |
Echinococcus granulosus | dual specificity | 0.0211 | 0.4959 | 0.6985 |
Onchocerca volvulus | Putative endochitinase | 0.0082 | 0.0768 | 0.2052 |
Loa Loa (eye worm) | cuticular endochitinase | 0.0073 | 0.0479 | 0.0517 |
Echinococcus multilocularis | dual specificity | 0.0211 | 0.4959 | 0.6985 |
Echinococcus multilocularis | dual specificity | 0.0097 | 0.1241 | 0.1195 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0073 | 0.0474 | 0.0825 |
Loa Loa (eye worm) | hypothetical protein | 0.0117 | 0.189 | 0.2578 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0073 | 0.0474 | 0.0825 |
Echinococcus multilocularis | dual specificity | 0.0211 | 0.4959 | 0.6985 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | = 0.2818 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of DNA Polymerase Beta. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 15.8489 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))] | ChEMBL. | No reference |
Potency (functional) | 26.6795 uM | PubChem BioAssay. qHTS for Inhibitors of PLK1-PDB (polo-like kinase 1 - polo-box domain): Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.